SCIE Projected Dividend Yield

SpectraScience Inc ( OTCBB : SCIE )

SpectraScience focuses on developing its WavSTAT ® Optical Biopsy System (WavSTAT). The WavSTAT illuminates tissue to distinguish between normal and pre-cancerous or cancerous tissue. Co. has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT Optical Biopsy System serve as a technology platform to facilitate multiple medical applications for cancer diagnosis. The WavSTAT4 Optical Biopsy System operates by using Ultraviolet laser light to illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening and, if warranted, to begin treatment during procedure.

20 YEAR PERFORMANCE RESULTS